Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
| General Information of Drug (ID: DR1747) | ||||||
|---|---|---|---|---|---|---|
| Drug Name |
Amifampridine
|
|||||
| Synonyms |
Amifampridine; Diamino-3,4 pyridine; Diamino-3,4-Pyridine; Firdapse; OYTKINVCDFNREN-UHFFFAOYSA-N; Pyridine, 3,4-diamino-; RU4S6E2G0J; amifampridin; pyridine-3,4-diamine; 3,4-DAP; 3,4-DIAMINOPYRIDINE; 3,4-Diaminopyridine, 98%; 3,4-Pyridinediamine; 3-amino-4-pyridinylamine; 4,5-Diaminopyridine; 54-96-6; 54-96-6 3,4-diaminopyridine; BRN 0110232; CAS-54-96-6; CHEMBL354077; DSSTox_CID_26715; DSSTox_GSID_46715; DSSTox_RID_81847; EINECS 200-220-9; MFCD00006401; NCGC00167560-01; NSC 521760; SC10; SMR000752913; UNII-RU4S6E2G0J; WT559; Zenas
|
|||||
| Indication | Lambert-Eaton syndrome [ICD11: 8C62] | Approved | [1] | |||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| Pharmaceutical Properties | Molecular Weight | 109.13 | Topological Polar Surface Area | 64.9 | ||
| Heavy Atom Count | 8 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| Cross-matching ID | ||||||
| The Metabolic Roadmap of This Drug | |||||
|---|---|---|---|---|---|
| The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.


